Iovance Biotherapeutics Inc. Common Stock vs PNC Financial Services Group Inc. (The) Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.45 (market cap $6.04B), while PNC Financial Services Group Inc. (The) Common Stock trades at $220 (market cap $87.64B). The key difference: PNC Financial Services Group Inc. (The) Common Stock is far larger — about 14.5× Iovance Biotherapeutics Inc. Common Stock's market cap, and PNC Financial Services Group Inc. (The) Common Stock pays a 3.64% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IOVA | PNC | |
|---|---|---|
Market Cap | $6.04B | $87.64B |
Volume | 14,805,993 | 1,687,662 |
Sector | Health | Financials |
52-Week High | $14.82 | $256.97 |
52-Week Low | $1.81 | $178.37 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $5.97B | $144.63B |
Dividend Yield | — | 3.64% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →PNC Financial Services Group is a financial services holding company. Its businesses include retail banking, corporate and institutional banking, and asset management.
Read more on PNC →